Corrigendum to "Berberine-induced LDLR up-regulation involves JNK pathway" [Biochem. Biophys. Res. Commun. 362 (2007) 853-857] (DOI:10.1016/j.bbrc.2007.08.060);Berberine-induced LDLR up-regulation involves JNK pathway

Biochemical and Biophysical Research Communications

Volumn 362, Issue 4, 2007, Pages 853-857

  Lee, Seahyoung ^a   Lim, Hyun Joung ^b   Park, Jin Hee ^b   Lee, Kuy Sook ^b   Jang, Yangsoo ^a   Park, Hyun Young ^b  

^a Yonsei University College of Medicine   (South Korea)

^b Korea National Institute of Health   (South Korea)

Author keywords

Berberine; JNK pathway; LDLR

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ALKALOID; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BERBERINE; BETA ACTIN; LOW DENSITY LIPOPROTEIN RECEPTOR; LUCIFERASE; MESSENGER RNA; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PROTEIN C JUN; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; WORTMANNIN;

ARTICLE; BINDING SITE; CONTROLLED STUDY; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HERB; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 34548591723     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.05.111     Document Type: Erratum

References (17)

1. Rabbani G.H., Butler T., Knight J., Sanyal S.C., and Alam K. Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic Escherichia coli and Vibrio cholerae. J. Infect. Dis. 155 (1987) 979-984
2. Subbaiah T.V., and Amin A.H. Effect of berberine sulphate on Entamoeba histolytica. Nature 215 (1967) 527-528
3. Kong W., Wei J., Abidi P., Lin M., Inaba S., Li C., Wang Y., Wang Z., Si S., Pan H., Wang S., Wu J., Wang Y., Li Z., Liu J., and Jiang J.D. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat. Med. 10 (2004) 1344-1351
4. Abidi P., Chen W., Kraemer F.B., Li H., and Liu J. The medicinal plant goldenseal is a natural LDL-lowering agent with multiple bioactive components and new action mechanisms. J. Lipid Res. 47 (2006) 2134-2147
5. Brown M.S., and Goldstein J.L. A receptor-mediated pathway for cholesterol homeostasis. Science 232 (1986) 34-47
6. Abidi P., Zhou Y., Jiang J.D., and Liu J. Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 2170-2176
7. Bennett B.L., Sasaki D.T., Murray B.W., O′Leary E.C., Sakata S.T., Xu W., Leisten J.C., Motiwala A., Pierce S., Satoh Y., Bhagwat S.S., Manning A.M., and Anderson D.W. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA 98 (2001) 13681-13686
8. Chen Y.R., and Tan T.H. Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin. Oncogene 17 (1998) 173-178
9. Collett G.P., and Campbell F.C. Curcumin induces c-jun N-terminal kinase-dependent apoptosis in HCT116 human colon cancer cells. Carcinogenesis 25 (2004) 2183-2189
10. Moussavi M., Assi K., Gomez-Munoz A., and Salh B. Curcumin mediates ceramide generation via the de novo pathway in colon cancer cells. Carcinogenesis 27 (2006) 1636-1644
11. Kamath R., Jiang Z., Sun G., Yalowich J.C., and Baskaran R. c-Abl kinase regulates curcumin-induced cell death through activation of c-Jun N-terminal kinase. Mol. Pharmacol. 71 (2007) 61-72
12. Tang G., Minemoto Y., Dibling B., Purcell N.H., Li Z., Karin M., and Lin A. Inhibition of JNK activation through NF-kappaB target genes. Nature 414 (2001) 313-317
13. De Smaele E., Zazzeroni F., Papa S., Nguyen D.U., Jin R., Jones J., Cong R., and Franzoso G. Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling. Nature 414 (2001) 308-313
14. Maulik N., Sato M., Price B.D., and Das D.K. An essential role of NFkappaB in tyrosine kinase signaling of p38 MAP kinase regulation of myocardial adaptation to ischemia. FEBS Lett. 429 (1998) 365-369
15. Huang W., Batra S., Korrapati S., Mishra V., and Mehta K.D. Selective repression of low-density lipoprotein receptor expression by SP600125: coupling of histone H3-Ser10 phosphorylation and Sp1 occupancy. Mol. Cell. Biol. 26 (2006) 1307-1317
16. Dawson P.A., Hofmann S.L., van der Westhuyzen D.R., Sudhof T.C., Brown M.S., and Goldstein J.L. Sterol-dependent repression of low density lipoprotein receptor promoter mediated by 16-base pair sequence adjacent to binding site for transcription factor Sp1. J. Biol. Chem. 263 (1988) 3372-3379
17. Sudhof T.C., van der Westhuyzen D.R., Goldstein J.L., Brown M.S., and Russell D.W. Three direct repeats and a TATA-like sequence are required for regulated expression of the human low density lipoprotein receptor gene. J. Biol. Chem. 262 (1987) 10773-10779